178 related articles for article (PubMed ID: 15883178)
1. Antibiotic susceptibilities of Legionella pneumophila strain Paris in THP-1 cells as determined by real-time PCR assay.
Roch N; Maurin M
J Antimicrob Chemother; 2005 Jun; 55(6):866-71. PubMed ID: 15883178
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species.
Higa F; Akamine M; Haranaga S; Tohyama M; Shinzato T; Tateyama M; Koide M; Saito A; Fujita J
J Antimicrob Chemother; 2005 Dec; 56(6):1053-7. PubMed ID: 16260445
[TBL] [Abstract][Full Text] [Related]
3. Direct detection of Legionella species from bronchoalveolar lavage and open lung biopsy specimens: comparison of LightCycler PCR, in situ hybridization, direct fluorescence antigen detection, and culture.
Hayden RT; Uhl JR; Qian X; Hopkins MK; Aubry MC; Limper AH; Lloyd RV; Cockerill FR
J Clin Microbiol; 2001 Jul; 39(7):2618-26. PubMed ID: 11427579
[TBL] [Abstract][Full Text] [Related]
4. Rifampicin-macrolide synergy against Legionella pneumophila serogroup 1 in human macrophages using a quantitative real-time PCR assay.
Descours G; Ginevra C; Ader F; Forey F; Lina G; Etienne J; Jarraud S
Int J Antimicrob Agents; 2011 Aug; 38(2):188-9. PubMed ID: 21641188
[No Abstract] [Full Text] [Related]
5. In vitro and intracellular activities of LBM415 (NVP PDF-713) against Legionella pneumophila.
Edelstein PH; Hu B; Edelstein MA
Antimicrob Agents Chemother; 2005 Jun; 49(6):2533-5. PubMed ID: 15917565
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic studies of moxifloxacin and erythromycin against intracellular Legionella pneumophila in an in vitro kinetic model.
Tano E; Cars O; Löwdin E
J Antimicrob Chemother; 2005 Jul; 56(1):240-2. PubMed ID: 15919770
[TBL] [Abstract][Full Text] [Related]
7. Design and implementation of a protocol for the detection of Legionella in clinical and environmental samples.
Nazarian EJ; Bopp DJ; Saylors A; Limberger RJ; Musser KA
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):125-32. PubMed ID: 18621500
[TBL] [Abstract][Full Text] [Related]
8. Activity of finafloxacin, a novel fluoroquinolone with increased activity at acid pH, towards extracellular and intracellular Staphylococcus aureus, Listeria monocytogenes and Legionella pneumophila.
Lemaire S; Van Bambeke F; Tulkens PM
Int J Antimicrob Agents; 2011 Jul; 38(1):52-9. PubMed ID: 21596526
[TBL] [Abstract][Full Text] [Related]
9. Development of conventional and real-time NASBA for the detection of Legionella species in respiratory specimens.
Loens K; Beck T; Goossens H; Ursi D; Overdijk M; Sillekens P; Ieven M
J Microbiol Methods; 2006 Dec; 67(3):408-15. PubMed ID: 16730822
[TBL] [Abstract][Full Text] [Related]
10. Activities of tigecycline and comparators against Legionella pneumophila and Legionella micdadei extracellularly and in human monocyte-derived macrophages.
Bopp LH; Baltch AL; Ritz WJ; Michelsen PB; Smith RP
Diagn Microbiol Infect Dis; 2011 Jan; 69(1):86-93. PubMed ID: 21146719
[TBL] [Abstract][Full Text] [Related]
11. Wild-type MIC distribution and epidemiological cut-off values in clinical Legionella pneumophila serogroup 1 isolates.
Bruin JP; Ijzerman EP; den Boer JW; Mouton JW; Diederen BM
Diagn Microbiol Infect Dis; 2012 Jan; 72(1):103-8. PubMed ID: 22100012
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes.
Baltch AL; Bopp LH; Smith RP; Michelsen PB; Ritz WJ
J Antimicrob Chemother; 2005 Jul; 56(1):104-9. PubMed ID: 15941776
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a human monocytic cell line THP-1 model for assay of the intracellular activities of antimicrobial agents against Legionella pneumophila.
Takemura H; Yamamoto H; Kunishima H; Ikejima H; Hara T; Kanemitsu K; Terakubo S; Shoji Y; Kaku M; Shimada J
J Antimicrob Chemother; 2000 Oct; 46(4):589-94. PubMed ID: 11020257
[TBL] [Abstract][Full Text] [Related]
14. [Activity of macrolides and fluoroquinolones against intracellular Legionella pneumophila].
Yu LL; Hu BJ; Huang SL; Zhou ZY; Tao LL
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):409-12. PubMed ID: 21781510
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of Duopath Legionella lateral flow assay against the conventional culture method using Legionella pneumophila and Legionella anisa strains.
Koide M; Haranaga S; Higa F; Tateyama M; Yamane N; Fujita J
Jpn J Infect Dis; 2007 Jul; 60(4):214-6. PubMed ID: 17642537
[TBL] [Abstract][Full Text] [Related]
16. Detection of Legionella pneumophila in water samples by species-specific real-time and nested PCR assays.
Fiume L; Bucci Sabattini MA; Poda G
Lett Appl Microbiol; 2005; 41(6):470-5. PubMed ID: 16305672
[TBL] [Abstract][Full Text] [Related]
17. Molecular evaluation of antibiotic susceptibility of Tropheryma whipplei in axenic medium.
Boulos A; Rolain JM; Mallet MN; Raoult D
J Antimicrob Chemother; 2005 Feb; 55(2):178-81. PubMed ID: 15650004
[TBL] [Abstract][Full Text] [Related]
18. Sensitive, real-time PCR detects low-levels of contamination by Legionella pneumophila in commercial reagents.
Shen H; Rogelj S; Kieft TL
Mol Cell Probes; 2006; 20(3-4):147-53. PubMed ID: 16632318
[TBL] [Abstract][Full Text] [Related]
19. Identification and differentiation of Legionella pneumophila and Legionella spp. with real-time PCR targeting the 16S rRNA gene and species identification by mip sequencing.
Stølhaug A; Bergh K
Appl Environ Microbiol; 2006 Sep; 72(9):6394-8. PubMed ID: 16957269
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of various antibiotics against clinical strains of Legionella species isolated in Japan.
Miyashita N; Kobayashi I; Higa F; Aoki Y; Kikuchi T; Seki M; Tateda K; Maki N; Uchino K; Ogasawara K; Kurachi S; Ishikawa T; Ishimura Y; Kanesaka I; Kiyota H; Watanabe A
J Infect Chemother; 2018 May; 24(5):325-329. PubMed ID: 29459000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]